Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Potassium; urine

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

A urine test for potassium measurement, identified by CPT® Code 84133, is a diagnostic procedure that evaluates the concentration of potassium in urine. Potassium is a vital electrolyte that plays a crucial role in various physiological functions, including the regulation of heart rhythm, muscle contraction, and nerve transmission. The test is particularly important in assessing conditions that may lead to abnormal potassium levels, which can have significant health implications. Elevated potassium levels in urine may indicate underlying issues such as kidney disease, Cushing's syndrome, hyperaldosteronism, eating disorders, diabetic or metabolic acidosis, and hypomagnesemia. Additionally, certain diuretics can also cause increased potassium excretion. Conversely, decreased potassium levels may be associated with adrenal gland insufficiency, hypoaldosteronism, and the use of specific medications, including beta blockers, lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs). The test can be performed using either a 24-hour urine collection or a random urine sample, and the analysis is typically conducted using a quantitative ion-selective electrode method, which provides precise measurements of potassium concentration in the urine.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The potassium urine test (CPT® Code 84133) is indicated for various clinical scenarios where monitoring potassium levels is essential. The following conditions may warrant this test:

  • Kidney Disease Elevated potassium levels may suggest impaired kidney function, necessitating further evaluation.
  • Cushing's Syndrome This condition can lead to increased potassium excretion, making the test relevant for diagnosis and management.
  • Hyperaldosteronism Excessive aldosterone can cause potassium loss, thus monitoring is crucial.
  • Eating Disorders Conditions such as bulimia can affect potassium levels, making this test important for assessment.
  • Diabetic/Metabolic Acidosis These metabolic disturbances can alter potassium balance, warranting evaluation through this test.
  • Hypomagnesemia Low magnesium levels can influence potassium levels, making this test relevant for comprehensive metabolic assessment.
  • Medication Monitoring Certain diuretics and other medications may affect potassium levels, necessitating regular monitoring.

2. Procedure

The procedure for obtaining a potassium urine test involves specific steps to ensure accurate results. The following outlines the procedural steps:

  • Sample Collection A urine sample is collected, which can either be a 24-hour collection or a random sample. For a 24-hour collection, the patient is instructed to collect all urine produced over a 24-hour period, ensuring that the sample is stored properly to maintain its integrity. For a random sample, the patient provides a single urine specimen at any time of the day.
  • Sample Preparation Once the urine sample is collected, it is prepared for analysis. This may involve mixing the sample to ensure homogeneity and may require specific handling to prevent contamination or degradation of the sample.
  • Testing Method The prepared urine sample is then analyzed using a quantitative ion-selective electrode method. This technique allows for precise measurement of potassium concentration in the urine, providing reliable results that can be interpreted in the context of the patient's clinical condition.

3. Post-Procedure

After the potassium urine test is completed, the results are typically reviewed by a healthcare professional. Depending on the findings, further evaluation or treatment may be necessary. Patients may be advised on any follow-up actions based on their potassium levels, including dietary modifications or adjustments to medications that may affect potassium balance. It is important for healthcare providers to communicate the results clearly to the patient and discuss any implications for their health and treatment plan.

Short Descr ASSAY OF URINE POTASSIUM
Medium Descr POTASSIUM URINE
Long Descr Potassium; urine
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
GZ Item or service expected to be denied as not reasonable and necessary
Q4 Service for ordering/referring physician qualifies as a service exemption
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
AY Item or service furnished to an esrd patient that is not for the treatment of esrd
GA Waiver of liability statement issued as required by payer policy, individual case
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GW Service not related to the hospice patient's terminal condition
GX Notice of liability issued, voluntary under payer policy
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
PN Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital
Q3 Live kidney donor surgery and related services
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
Date
Action
Notes
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"